Cardinal Health Inc. Annual Valuation – 2015 $CAH
Cardinal Health does not qualify for either the Defensive Investor or the Enterprising Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years, and high PEmg and PB ratios. The Enterprising Investor takes issue with the level of debt relative to the current assets. As a result, any purchase of the company is made with a speculative nature behind it. That said, any speculator interested in pursuing the company should still proceed to the next part of the analysis, which is a determination of the company’s intrinsic value.
With regard to that intrinsic value, the company has grown its EPSmg (normalized earnings) from $2.81 in 2011 to only an estimated $3.08 for 2015. This level of demonstrated growth does not support the market’s implied estimate for earnings growth of 9.01% over the next 7-10 years. In fact, actual growth has been closer to 1.94% in recent years. The ModernGraham valuation model therefore returns an estimate of intrinsic value below the current price, indicating the company is overvalued at the present time.
Be sure to check out previous ModernGraham valuations of Cardinal Health Inc. (CAH)Â for greater perspective!
Read the full valuation on Seeking Alpha!
Disclaimer: Â The author did not hold a position in Cardinal Health Inc. (CAH)Â at the time of publication and had no intention of changing that position within the next 72 hours. Â Logo taken from Wikipedia for the sole purpose of identifying the company; this article is not affiliated with the company in any manner.
